✦ LIBER ✦

A Phase Ib dose-escalation study to evaluate safety and tolerability of the addition of the aminopeptidase inhibitor tosedostat (CHR-2797) to paclitaxel in patients with advanced solid tumours

✍ Scribed by van Herpen, C M L; Eskens, F A L M; de Jonge, M; Desar, I; Hooftman, L; Bone, E A; Timmer-Bonte, J N H; Verweij, J

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I dose-escalation study to evalu

✍ Desar, I M E; Timmer-Bonte, J N H; Burger, D M; van der Graaf, W T A; van Herpen 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 349 KB

A phase I dose escalation study of the p

✍ Edwina N. Scott; Anne L. Thomas; L. Rhoda Molife; Samreen Ahmed; Sarah Blagden; 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 253 KB

A Phase I study to assess the safety, to

✍ J. R. Infante; R. Kurzrock; J. Spratlin; H. A. Burris; S. G. Eckhardt; J. Li; K. 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 338 KB

The insulin-like growth factor-I recepto

✍ Molife, L R; Fong, P C; Paccagnella, L; Reid, A H M; Shaw, H M; Vidal, L; Arkena 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 469 KB

A two-part Phase II study of cediranib i

✍ Claire L. Mitchell; J. P. B. O’Connor; C. Roberts; Y. Watson; A. Jackson; S. Che 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 631 KB

A phase I, open-label, randomized crosso

✍ Suzanne Leijen; Patricia M. M. B. Soetekouw; T. R. Jeffry Evans; Marianne Nicols 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 303 KB